Editorial Comment from Dr Yuasa to Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.
Takeshi YuasaPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)